Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

It starts with a screen, a blinking cursor, and a designer who suddenly isn’t sure if they’re in control anymore. Artificial intelligence has sunk its claws into the graphic design industry, ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing ...

Sundance 2025 might be over, but these are some of the films that people will be talking about these films for the rest of ...

The first participants have been vaccinated with an investigational Ebola Sudan vaccine candidate provided by IAVI, a nonprofit scientific ...

It is important to recognise that certain ministries, particularly those overseeing large-scale infrastructure projects like ...

Sleeping sickness is no longer a health threat in Guinea, which may be a tipping point in the continent’s efforts to beat the ...